Pharmacological treatment of depression: A systematic review comparing clinical practice guideline recommendations

作者
Franciele Cordeiro Gabriel,Daniela Oliveira de Melo,Renério Fráguas,Nathália Celini Leite-Santos,Rafael Augusto Mantovani Silva,Eliane Ribeiro
出处
期刊:PLOS ONE [Public Library of Science]
卷期号:15 (4): e0231700-e0231700 被引量:112
标识
DOI:10.1371/journal.pone.0231700
摘要

Depression affects over 300 million individuals worldwide and is responsible for most of the 800,000 annual suicides. Clinical practice guidelines (CPGs) for treatment of depression, founded on scientific evidence, are essential to improve patient care. However, economic and sociocultural factors may influence CPG elaboration, potentially leading to divergences in their recommendations. Consequently, we analyzed pharmacological recommendations for the treatment of depression from the most relevant CPGs. We included four CPGs with scores ≥ 80% for Domain 3 (rigor of development) on the Appraisal of Guidelines for Research and Evaluation and two other commonly used CPGs. The recommendations, their strengths, and the level of evidence were extracted from each CPG by two independent researchers and grouped as follows: (1) general recommendations for the pharmacological treatment for depression (suicide risk, acute treatment, continuation and maintenance phases, and treatment discontinuation); (2) treatment of non-responsive or partially responsive patients; and (3) treatment for subtypes of depression (chronic, psychotic, catatonic, melancholic, seasonal, somatic, mixed, and atypical). Only 50% of CPGs included recommendations for the risk of suicide associated with pharmacotherapy. All CPGs included serotonin selective reuptake inhibitors (SSRIs) as first-line treatment; however, one CPG also included agomelatine, milnacipran, and mianserin as first-line alternatives. Recommendations for depression subtypes (catatonic, atypical, melancholic) were included in three CPGs. The strength of recommendation and level of evidence clearly differed among CPGs, especially regarding treatment augmentation strategies. We conclude that, although CPGs converged in some recommendations (e.g., SSRIs as first-line treatment), they diverged in cardinal topics including the absence of recommendations regarding the risk of suicide associated with pharmacotherapy. Consequently, the recommendations listed in a specific CPG should be followed with caution.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
孙浩文发布了新的文献求助10
刚刚
QQ发布了新的文献求助10
1秒前
Huaaaaay完成签到,获得积分10
1秒前
1秒前
勒言完成签到,获得积分10
1秒前
张张的应助被含糊的静芙采纳,获得10
2秒前
hazeoO发布了新的文献求助10
3秒前
3秒前
麦粑块发布了新的文献求助10
3秒前
岳鑫发布了新的文献求助30
3秒前
水沐菁华发布了新的文献求助10
5秒前
诚心的琦完成签到,获得积分10
5秒前
5秒前
俭朴南风发布了新的文献求助10
5秒前
6秒前
6秒前
gsokok完成签到,获得积分10
8秒前
盒子发布了新的文献求助10
8秒前
王亚娟发布了新的文献求助10
9秒前
JamesPei的应助被lxlx111采纳,获得10
9秒前
科研通AI6.4的应助被lanchuan采纳,获得10
9秒前
10秒前
CodeCraft的应助被时思采纳,获得10
10秒前
宇明完成签到,获得积分10
10秒前
Huaaaaay发布了新的文献求助10
11秒前
十四完成签到,获得积分10
11秒前
11秒前
Paranoieam完成签到,获得积分10
11秒前
11秒前
ESTHERDY完成签到,获得积分10
12秒前
14秒前
xzlijingjing完成签到 ,获得积分10
14秒前
王亚娟完成签到,获得积分10
14秒前
乐乐的应助被苏小咩采纳,获得10
14秒前
15秒前
宇明发布了新的文献求助10
15秒前
催化剂完成签到,获得积分10
15秒前
ESTHERDY发布了新的文献求助20
16秒前
kkkkkkk完成签到 ,获得积分10
16秒前
勒言发布了新的文献求助10
16秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183263
求助须知:如何正确求助?哪些是违规求助? 9572532
关于积分的说明 21826339
捐赠科研通 7780187
什么是DOI,文献DOI怎么找? 3433993
关于科研通互助平台的介绍 2558131
邀请新用户注册赠送积分活动 2480239